MDM4 and glioblastoma: Therefore, based on our results, we hypothesize that the SNP rs4252707 may contribute to the risk of developing non-GBM glioma by somehow influencing the expression of MDM4, such as by affecting the splice sites or by being closely linked with some functional variations.